MAP2K7 and breast carcinoma: These results are consistent with other studies, for example, NVP-BEZ235 was found to be cytotoxic to breast cancer cell lines (Serra et al, 2008), whereas MEK inhibitors were reported to be cytostatic (Kohno and Pouyssegur, 2006).